European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis
FOSTER CITY, Calif. & MECHELEN, Belgium–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Marketing Authorization...